Related references
Note: Only part of the references are listed.The FGF23 and Klotho system beyond mineral metabolism
Makoto Kuro-o
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System
Lili Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
Peter Wohlfahrt et al.
JACC-HEART FAILURE (2015)
Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
Ming Chang Hu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody
Sarah L. Barker et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Reduced Klotho is associated with the presence and severity of coronary artery disease
Juan F. Navarro-Gonzalez et al.
HEART (2014)
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
Jacob A. Udell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency
Rika Jimbo et al.
KIDNEY INTERNATIONAL (2014)
Effect of Renin-Angiotensin System Blockade on Soluble Klotho in Patients with Type 2 Diabetes, Systolic Hypertension, and Albuminuria
Janaka Karalliedde et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Expression of FGF23/KLOTHO system in human vascular tissue
Javier Donate-Correa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Effect of renin angiotensin system blockade on soluble Klotho, arterial stiffness and albuminuria in patients with Type 2 Diabetes and Systolic Hypertension
G. Maltese et al.
Artery Research (2013)
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
Marc S. Sabatine et al.
CIRCULATION (2012)
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
Kenneth Lim et al.
CIRCULATION (2012)
Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis
Yoshiko Shimamura et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals CHS (Cardiovascular Health Study)
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Relationship of Fibroblast Growth Factor 23 with Left Ventricle Mass Index and Coronary Calcificaton in Chronic Renal Disease
Abdulkadir Unsal et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
The Putative Role of the Antiageing Protein Klotho in Cardiovascular and Renal Disease
Giuseppe Maltese et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2012)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease
Martin H. de Borst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Plasma Klotho and Mortality Risk in Older Community-Dwelling Adults
Richard D. Semba et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy
Hye Eun Yoon et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases
Jacques Bernheim et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects
Yuji Yamazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Association Between Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients - Comparison With B-Type Natriuretic Peptide and Cardiac Troponin T
Kazuaki Negishi et al.
CIRCULATION JOURNAL (2010)
Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
Heng Jung Hsu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutierrez et al.
CIRCULATION (2009)
Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
Masahide Mizobuchi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
Torbjorn Omland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease - The PEACE trial
Torbjorn Omland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
How fibroblast growth factor 23 works
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
KLOTHO allele status and the risk of early-onset occult coronary artery disease
DE Arking et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Angiotensin-converting enzyme 2 - A new cardiac regulator
M Boehm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage
H Mitani et al.
HYPERTENSION (2002)